Joseph Jorizzo to Humans
This is a "connection" page, showing publications Joseph Jorizzo has written about Humans.
Connection Strength
1.286
-
Schwartzberg L, Lin A, Jorizzo J. Cutaneous Manifestations of COVID-19. Cutis. 2021 Feb; 107(2):90-94.
Score: 0.041
-
Haidari W, Light JG, Castellanos B, Jorizzo JL. Cutis marmorata telangiectasia congenita with painful ulcerations. Dermatol Online J. 2020 Jun 15; 26(6).
Score: 0.039
-
Bomar L, Lewallen R, Jorizzo J. Localized acanthosis nigricans at the site of repetitive insulin injections. Cutis. 2020 Feb; 105(2):E20-E22.
Score: 0.038
-
Visconti MJ, Bashyam AM, Jorizzo JL. Statin-induced dermatomyositis for the practicing dermatologist: a review of the literature. Int J Dermatol. 2020 Mar; 59(3):383-387.
Score: 0.038
-
Shipman WD, Vernice NA, Demetres M, Jorizzo JL. An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. J Am Acad Dermatol. 2020 Mar; 82(3):709-722.
Score: 0.037
-
Dillingham CS, Jorizzo J. Managing Ulcers Associated with Pyoderma Gangrenosum with a Urinary Bladder Matrix and Negative-Pressure Wound Therapy. Adv Skin Wound Care. 2019 Feb; 32(2):70-76.
Score: 0.036
-
Aung-Din D, Heath M, Wechter T, Cline A, Feldman SR, Jorizzo JL. Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients With Geographic Tongue. JAMA Dermatol. 2018 12 01; 154(12):1481-1482.
Score: 0.035
-
Maderal AD, Lee Salisbury P, Jorizzo JL. Reply to: "Comment on 'Desquamative gingivitis: Clinical findings and diseases'". J Am Acad Dermatol. 2019 03; 80(3):e59.
Score: 0.035
-
Maderal AD, Lee Salisbury P, Jorizzo JL. Desquamative gingivitis: Clinical findings and diseases. J Am Acad Dermatol. 2018 05; 78(5):839-848.
Score: 0.034
-
Maderal AD, Lee Salisbury P, Jorizzo JL. Desquamative gingivitis: Diagnosis and treatment. J Am Acad Dermatol. 2018 05; 78(5):851-861.
Score: 0.034
-
Yan BY, Jorizzo JL. Management of Morgellons Disease With Low-Dose Trifluoperazine. JAMA Dermatol. 2018 02 01; 154(2):216-218.
Score: 0.033
-
Isak V, Jorizzo JL. Recent developments on treatment strategies and the prognosis of dermatomyositis: a review. J Dermatolog Treat. 2018 Aug; 29(5):450-459.
Score: 0.033
-
Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatolog Treat. 2018 Mar; 29(2):197-199.
Score: 0.032
-
Barilla S, Felix K, Jorizzo JL. Stressors in Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:71-77.
Score: 0.031
-
Anderson K, Ascanio NM, Kinney MA, Krowchuk DP, Jorizzo JL. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. J Dermatolog Treat. 2016; 27(1):64-6.
Score: 0.028
-
Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update. Am J Clin Dermatol. 2014 Oct; 15(5):413-23.
Score: 0.026
-
DeFilippis EM, Magro C, Jorizzo JL. Bowel-associated dermatosis - arthritis syndrome in a patient with ulcerative colitis: an extraintestinal manifestation of inflammatory bowel disease. Clin J Gastroenterol. 2014 Oct; 7(5):410-3.
Score: 0.026
-
Landis ET, Taheri A, Jorizzo JL. Gulliver's sign: A recognizable transition from inflammatory to healing stages of pyoderma gangrenosum. J Dermatolog Treat. 2015 Apr; 26(2):171-2.
Score: 0.025
-
Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol. 2013 Jan; 68(1 Suppl 1):S28-38.
Score: 0.023
-
Yosipovitch G, Tan A, LoSicco K, Manabat CG, Kannagra A, Carroll C, Chan YH, Ng P, Jorizzo J. A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore. Int J Dermatol. 2013 Jul; 52(7):813-9.
Score: 0.023
-
Strowd LC, Jorizzo JL. Review of dermatomyositis: establishing the diagnosis and treatment algorithm. J Dermatolog Treat. 2013 Dec; 24(6):418-21.
Score: 0.023
-
Kwatra SG, Jorizzo JL. Bullous pemphigoid: a case series with emphasis on long-term remission off therapy. J Dermatolog Treat. 2013 Oct; 24(5):327-31.
Score: 0.022
-
Kinney MA, Jorizzo JL. Small-vessel vasculitis. Dermatol Ther. 2012 Mar-Apr; 25(2):148-57.
Score: 0.022
-
Jorizzo JL, Markowitz O, Lebwohl MG, Bourcier M, Kulp J, Meng TC, Levy S. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses. J Drugs Dermatol. 2010 Sep; 9(9):1101-8.
Score: 0.020
-
Uhlenhake EE, Sangueza OP, Lee AD, Jorizzo JL. Spreading pigmented actinic keratosis: a review. J Am Acad Dermatol. 2010 Sep; 63(3):499-506.
Score: 0.019
-
Lee AD, Jorizzo JL. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach. Cutis. 2009 Sep; 84(3):169-75.
Score: 0.019
-
Namazi MR, Jorizzo JL. Ant-induced alopecia: a case report and literature review. Arch Dermatol. 2008 Nov; 144(11):1526-7.
Score: 0.017
-
Namazi MR, Hinckley ML, Jorizzo JL. Multiple collections of soft bluish nodules on the body. Familial glomangiomas. Arch Dermatol. 2008 Oct; 144(10):1383-8.
Score: 0.017
-
Jorizzo J, Grossman R, Nighland M. Tretinoin microsphere gel in younger acne patients. J Drugs Dermatol. 2008 Aug; 7(8 Suppl):s9-13.
Score: 0.017
-
Menter A, Vamvakias G, Jorizzo J. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. Cutis. 2008 Jun; 81(6):509-16.
Score: 0.017
-
Iorizzo LJ, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008 Jul; 59(1):99-112.
Score: 0.017
-
Neville JA, Williford PM, Jorizzo JL. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. J Drugs Dermatol. 2007 Sep; 6(9):910-4.
Score: 0.016
-
Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, McRae S, Fielder S, Lee JH. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007 Aug; 57(2):265-8.
Score: 0.016
-
Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis. 2006 Oct; 78(4):268-74.
Score: 0.015
-
Goldenberg G, Krowchuk DP, Jorizzo JL. Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream. J Dermatolog Treat. 2006; 17(2):121-3.
Score: 0.014
-
Goldenberg G, Sangueza OP, Jorizzo JL. Successful treatment of relapsing polychondritis with mycophenolate mofetil. J Dermatolog Treat. 2006; 17(3):158-9.
Score: 0.014
-
Hundley JL, Carroll CL, Lang W, Snively B, Yosipovitch G, Feldman SR, Jorizzo JL. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol. 2006 Feb; 54(2):217-20.
Score: 0.014
-
Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):500-8.
Score: 0.014
-
Goldenberg G, Jorizzo JL. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis. J Dermatolog Treat. 2005; 16(5-6):347-9.
Score: 0.013
-
Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Matching patients with therapy. Cutis. 2004 Dec; 74(6 Suppl):5-8.
Score: 0.013
-
Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Treatment options in the management of actinic keratosis. Cutis. 2004 Dec; 74(6 Suppl):9-17.
Score: 0.013
-
Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule. Cutis. 2004 Dec; 74(6 Suppl):18-23.
Score: 0.013
-
Jorizzo J, Weiss J, Furst K, VandePol C, Levy SF. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004 Jul; 140(7):813-6.
Score: 0.013
-
Jorizzo J. Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy? J Drugs Dermatol. 2004 Jan-Feb; 3(1):21-6.
Score: 0.013
-
Jorizzo JL. Current and novel treatment options for actinic keratosis. J Cutan Med Surg. 2004; 8 Suppl 3:13-21.
Score: 0.013
-
McCarty MA, Garton RA, Jorizzo JL. Complex aphthosis and Behçet's disease. Dermatol Clin. 2003 Jan; 21(1):41-8, vi.
Score: 0.012
-
Mc Carty MA, Jorizzo JL. Complex aphthosis: evaluation for Behçet's disease? Adv Exp Med Biol. 2003; 528:303-10.
Score: 0.012
-
Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis. 2002 Dec; 70(6):335-9.
Score: 0.012
-
Housman TS, Jorizzo JL. Anecdotal reports of 3 cases illustrating a spectrum of resistant common warts treated with cryotherapy followed by topical imiquimod and salicylic acid. J Am Acad Dermatol. 2002 Oct; 47(4 Suppl):S217-20.
Score: 0.011
-
Sangueza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Griffin JE, Fleischer AB, Jorizzo JL. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002 Aug; 47(2):251-7.
Score: 0.011
-
Jorizzo JL. Dermatomyositis: practical aspects. Arch Dermatol. 2002 Jan; 138(1):114-6.
Score: 0.011
-
Cline A, Cuellar-Barboza A, Jorizzo JL, Pichardo RO. Methotrexate for the Treatment of Recalcitrant Erosive Lichen Planus of the Vulva. JAMA Dermatol. 2020 02 01; 156(2):215-217.
Score: 0.010
-
Aung-Din D, Sahni DR, Jorizzo JL, Feldman SR. Morgellons disease: insights into treatment. Dermatol Online J. 2018 Nov 15; 24(11).
Score: 0.009
-
Ro T, Tull RZ, Cardwell LA, Farhangian ME, Moustafa F, Richardson I, Jorizzo JL, Feldman S, Huang W. A Pilot Study Characterizing Factors in Adherence to Cutaneous Lupus Treatment. J Cutan Med Surg. 2018 Sep/Oct; 22(5):530-532.
Score: 0.009
-
Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. 2018 02; 70(2):171-184.
Score: 0.008
-
Olinger RC, Jorizzo JL, Cerci FB. Lichen sclerosus et atrophicus: atypical case simulating lichen planus. Dermatol Online J. 2017 06 15; 23(6).
Score: 0.008
-
Halteh P, Jorizzo JL, Lipner SR. Darier disease: candy-cane nails and hyperkeratotic papules. Postgrad Med J. 2016 Jul; 92(1089):425-6.
Score: 0.007
-
Moustafa FA, Sandoval LF, Jorizzo JL, Huang WW. Systemic treatment of papular dermatitis: A retrospective study. J Dermatolog Treat. 2015 Oct; 26(5):431-4.
Score: 0.007
-
Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis. 2014 Nov; 94(5):255-9.
Score: 0.007
-
Baquerizo KL, Teague DJ, Strowd LC, Jorizzo JL, Sangueza OP. Painful plaques on extremities of a woman: challenge, answer. Diagnosis: Lupus erythematosus profundus with extensive calcification. Am J Dermatopathol. 2014 Jul; 36(7):588-9, 597.
Score: 0.006
-
Sugai DY, Gustafson CJ, De Luca JF, Davis SA, Jorizzo JL, O'Rourke KS, Feldman SR. Trends in the outpatient medication management of lupus erythematosus in the United States. J Drugs Dermatol. 2014 May; 13(5):545-52.
Score: 0.006
-
Baartman B, Kosari P, Warren CC, Ali S, Jorizzo JL, Sato M, Kurup SK. Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet's syndrome). Dermatology. 2014; 228(3):193-7.
Score: 0.006
-
Koch SB, Cerci FB, Jorizzo JL, Krowchuk DP. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients. J Dermatolog Treat. 2013 Dec; 24(6):435-8.
Score: 0.006
-
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86.
Score: 0.006
-
Kaufman WS, McNamara EK, Curtis AR, Kosari P, Jorizzo JL, Krowchuk DP. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome. Pediatr Dermatol. 2012 Mar-Apr; 29(2):135-40.
Score: 0.005
-
Eichenfield LE, Jorizzo JL, Dirschka T, Taub AF, Lynde C, Graeber M, Kerrouche N. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety. J Drugs Dermatol. 2010 Nov; 9(11):1395-401.
Score: 0.005
-
Strowd LC, Taylor SL, Jorizzo JL, Namazi MR. Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission. J Am Acad Dermatol. 2011 Mar; 64(3):490-4.
Score: 0.005
-
Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010 Apr; 62(4):646-54.
Score: 0.005
-
Gold LS, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin JC. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Cutis. 2010 Feb; 85(2):94-104.
Score: 0.005
-
Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009 Feb; 31(1):61-7.
Score: 0.004
-
Avshalumov K, Pichardo R, Jorizzo JL, Sangueza OP, Goldenberg G. Bullous mastocytosis: report of a patient and a brief review of the literature. Am J Dermatopathol. 2008 Oct; 30(5):455-7.
Score: 0.004
-
Walsh SN, Jorizzo JL, Haverstock C, Sangüeza OP. A linear orofacial macule. Am J Dermatopathol. 2008 Apr; 30(2):194-5.
Score: 0.004
-
Cohen JL, Jorizzo JL, Kircik LH. Use of a topical emulsion for wound healing. J Support Oncol. 2007 Nov-Dec; 5(10 Suppl 5):1-9.
Score: 0.004
-
Dawn A, Thevarajah S, Cayce KA, Carroll CL, Duque ML, Chan YH, Jorizzo JL, Yosipovitch G. Cutaneous blood flow in dermatomyositis and its association with disease severity. Skin Res Technol. 2007 Aug; 13(3):285-92.
Score: 0.004
-
Torti DC, Jorizzo JL, McCarty MA. Oral lichen planus: a case series with emphasis on therapy. Arch Dermatol. 2007 Apr; 143(4):511-5.
Score: 0.004
-
Del Rosso JQ, Draelos ZD, Jorizzo JL, Joseph WS, Ribotsky BM, Rich P. Modern methods to treat superficial fungal disease. Cutis. 2007 Feb; 79(2 Suppl):6-29.
Score: 0.004
-
Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006 Dec; 55(6):1003-13.
Score: 0.004
-
Sansbury JC, Cocuroccia B, Jorizzo JL, Gubinelli E, Gisondi P, Girolomoni G. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol. 2004 Jul; 51(1):126-31.
Score: 0.003
-
Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, Lee JH, Fox TL. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004 May; 50(5):714-21.
Score: 0.003
-
Hale EK, Jorizzo JL, Nehal KS, Perez MI, Robins P, Sarnoff D. Current concepts in the management of actinic keratosis. J Drugs Dermatol. 2004 Mar-Apr; 3(2 Suppl):S3-16.
Score: 0.003
-
Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol. 2003 Jan; 139(1):50-4.
Score: 0.003